⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VNRX News
VolitionRX Limited Common Stock
Form 8-K
sec.gov
VNRX
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium
prnewswire.com
VNRX
Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients
prnewswire.com
VNRX
Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference
prnewswire.com
VNRX
Volition Announces Detection of Over 95% of Early-Stage Cancers
prnewswire.com
VNRX
Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
prnewswire.com
VNRX
Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems
prnewswire.com
VNRX
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Volition Announces the Appointment of New Distributor for Nu.Q® Discover
prnewswire.com
VNRX